Literature DB >> 25022211

Pharmacological investigation of a HPLC/MS standardized three herbal extracts containing formulae (Bu-Shen-Yi-Qi-Tang) on airway inflammation and hypothalamic-pituitary-adrenal axis activity in asthmatic mice.

Q L Luo1, M Nurahmat2, M H Li1, J Sun1, M X Chen1, F Liu1, Y Wei3, J C Dong4.   

Abstract

Bu-Shen-Yi-Qi-Tang (BSYQT) which is prescribed on the basis of clinical experience is commonly used in clinic of traditional Chinese medicine (TCM) for asthma treatment. The components of BSYQT include Radix Astragali (RA), Herba Epimedii (HE) and Radix Rehmanniae (RR). The aim of this study was to screen extracts of BSYQT with best anti-inflammatory activity in asthmatic mice, and separate and identify the chemical compounds in them. Our results suggested that 60% ethanol extract of herbs (H60) and granules (G60) of BSYQT were the two extracts with best anti-inflammatory activity and effects of H60 were a little better than that of G60. High-performance liquid chromatography coupled to electrospray ionization and quadrupole time-of-flight mass spectrometry (HPLC-ESI-Q-TOF-MS/MS) analysis of the major chemical compounds of H60 and G60 revealed that 56 and 42 peaks were identified separately in H60 and G60. Further analysis revealed that 38 compounds were identified shared by H60 and G60, and 18 compounds were only in H60. There were 25 compounds in HE, 6 compounds in RR and 7 compounds in RA in the 38 compounds shared by G60 and H60. These 38 chemical components were tentatively considered the material basis of the anti-inflammatory activity of G60 and H60. The differences in the amount of the 38 chemical components as well as the 18 chemical components only in H60 were tentatively considered responsible for the activity differences between H60 and G60. In conclusion, these results suggested that extracts of BSYQT had inhibitory effects on airway inflammation in asthmatic mice, and H60 and G60 demonstrated the best anti-inflammatory activity. The 38 chemical compounds shared by H60 and G60 were responsible for their anti-inflammatory activity in asthmatic mice, and the differences in chemical compounds contents and amounts between H60 and G60 were responsible for this activity differences. This work would provide support for further pharmacodynamic material basis study of BSYQT.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Airway inflammation; Bu-Shen-Yi-Qi-Tang; Extracts; HPLC–ESI-Q-TOF-MS/MS; Hypothalamic-pituitary-adrenal axis; Traditional Chinese medicine

Mesh:

Substances:

Year:  2014        PMID: 25022211     DOI: 10.1016/j.phymed.2014.06.006

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  6 in total

1.  Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology.

Authors:  Yuanyuan Zhong; Lingli Hu; Wenjing Chen; Bin Wang; Jing Sun; Jingcheng Dong
Journal:  BMC Complement Med Ther       Date:  2022-06-07

2.  The Anti-Inflammatory Effects of Invigorating Kidney and Supplementing Qi Chinese Herbal Formulae in Asthma Patients.

Authors:  Lingwen Kong; Hongying Zhang; Yuxue Cao; Jingjing Le; Jinfeng Wu; Baojun Liu; Meixia Chen; Yijie Du; Jia Wang; Genfa Wang; Tao Yi; Xianmei Zhou; Gang Wang; Qing Miao; Suyun Li; Naiqing Zhao; Jingcheng Dong
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-27       Impact factor: 2.629

3.  Efficacy and safety of modified Bushen Yiqi formulas (MBYF) as an add-on to formoterol and budesonide in the management of COPD: study protocol for a multicentre, double-blind, placebo-controlled, parallel-group, randomized clinical trial: FB-MBYF Trial.

Authors:  Qing Kong; Yuxue Cao; Zhen Gao; Jing Sun; Hongying Zhang; Yijie Du; Yubao Lv; Sihan Zhou; Zihui Tang; Baojun Liu; Jingcheng Dong
Journal:  Trials       Date:  2022-02-14       Impact factor: 2.279

Review 4.  Classic mechanisms and experimental models for the anti-inflammatory effect of traditional Chinese medicine.

Authors:  Du Hongzhi; Hou Xiaoying; Guo Yujie; Chen Le; Miao Yuhuan; Liu Dahui; Huang Luqi
Journal:  Animal Model Exp Med       Date:  2022-04-12

5.  Formula Compatibility Identification of Dachengqi Decoction Based on the Effects of Absorbed Components in Cerulein-Injured Pancreatic AR42J Cells.

Authors:  Yumei Zhang; Lin Zhu; Jia Wang; Jianlei Zhao; Xianlin Zhao; Hui Guo; Juan Li; Wenfu Tang
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-31       Impact factor: 2.629

6.  A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Loki zupa in Patients With Chronic Asthma.

Authors:  Yubao Lv; Ying Wei; Muhammadjan Abduwaki; Tohti Jurat; Fengsen Li; Huaizhen Wang; Yuhua Wu; Zheng Li; Bo Liu; Hongjun Yin; Yuxue Cao; Mammat Nurahmat; Zihui Tang; Jingcheng Dong
Journal:  Front Pharmacol       Date:  2018-04-10       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.